XML 31 R9.htm IDEA: XBRL DOCUMENT v3.8.0.1
FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT
12 Months Ended
Dec. 31, 2017
FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT  
FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT

NOTE 4 - FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT:

 

a.   Financial risk management:

 

1)           Financial risk factors

 

The Company’s activities expose it to a variety of financial risks: market risk (including foreign exchange risk and price risks), credit and interest risks, and liquidity risk. The Company’s overall risk management program focuses on the unpredictability of financial markets and seeks to minimize potential adverse effects on the Company’s results of operations and financial position.

 

Risk management is performed by the Chief Financial Officer of the Company who identifies and evaluates financial risks in close cooperation with the Company’s Chief Executive Officer.

 

The Company’s finance department is responsible for carrying out financial risk management activities in accordance with policies approved by its board of directors. The board of directors provides general guidelines for overall financial risk management as well as policies dealing with specific areas, such as exchange rate risk, interest rate risk, credit risk, use of financial instruments and investment of excess cash. In order to minimize market risk and credit risk, the Company has invested the majority of its cash balances in low-risk investments, such as (i) highly-rated bank deposits with terms of up to one-year term with exit points and (ii) a managed portfolio of selected corporate bonds, comprised of a diversified mix of highly-rated bonds. No more than 10% of the total value of the Company’s portfolio is invested in a single bond issuer.

 

(a)   Market risks

 

The Company might be exposed to foreign exchange risk as a result of making payments to employees or service providers and investment of some liquidity in currencies other than the U.S. dollar (i.e., the Functional Currency). The Company manages the foreign exchange risk by aligning the currencies for holding liquidity with the currencies of expected expenses, based on the expected cash flows of the Company. Had the Functional Currency of the Company been stronger by 5% against the NIS, assuming all other variables remained constant, the Company would have recognized an additional expense of $56,,000 $78,000 and $12,000 in profit or loss for the years ended, December 31, 2017, 2016 and 2015, respectively. The foreign exchange risks associated with these balances are immaterial.

 

(b)   Credit and interest risks

 

Credit and interest risks arise from cash and cash equivalents, deposits with banks, financial assets at fair value through profit or loss, as well as receivables. A substantial portion of liquid instruments of the Company is invested in short-term deposits or corporate bonds in highly-rated banks. The Company estimates that since the liquid instruments are mainly invested for the short term and with highly-rated institutions, the credit and interest risks associated with these balances are low.

 

Credit risk is the risk that customers may fail to pay their debts. The Company manages credit risk by setting credit limits, performing controls and monitoring qualitative and quantitative indicators of trade receivable balances such as the period of credit taken and overdue payments. Customer credit risk also arises as a result of the concentration of the Company’s revenues with its largest customers. See also note 22b.

 

(c)   Liquidity risk

 

Prudent liquidity risk management requires maintaining sufficient cash and the availability of funding through an adequate amount of committed credit facilities. Management monitors rolling forecasts of the Company’s liquidity reserve (comprising of cash and cash equivalents, deposits and financial assets through profit or loss). This is generally carried out based on the expected cash flow in accordance with practice and limits set by the management of the Company.

 

As of December 31, 2017, the Company has generated revenues from commercialization and promotional activities; however, and as no sufficient revenue from the commercial operations was generated to compensate for operating expenses and as sales, royalties or commercialization revenues from the therapeutic candidates have not been generated, it is exposed to liquidity risk.

 

As of December 31, 2017 and 2016, the Company’s non-derivative financial liabilities include accounts payable, accrued expenses and payable in respect of intangible asset purchase for a period of less than 1 year.

 

2)           Capital risk management

 

The Company’s objectives when managing capital are to safeguard the Company’s ability to continue as a going concern in order to provide returns for shareholders, maintain optimal capital structure and to reduce the cost of capital.

 

3)           Fair value estimation

 

The following is an analysis of financial instruments measured at fair value using valuation methods. The different levels have been defined as follows:

 

·

quoted prices (unadjusted) in active markets for identical assets or liabilities (level 1)

·

inputs other than quoted prices included within level 1 that are observable for the asset or liability, either directly (that is, as prices) or indirectly (that is, derived from prices) (level 2)

·

inputs for the asset or liability that are not based on observable market data (that is, unobservable inputs) (level 3)

 

The fair value of financial instruments traded in active markets is based on quoted market prices at dates of Statements of Financial Position. A market is regarded as active if quoted prices are readily and regularly available from an exchange, dealer, broker, industry group, pricing service, or regulatory agency, and those prices represent actual and regularly occurring market transactions on an arm’s length basis. These instruments are included in level 1.

 

The fair value of financial instruments that are not traded in an active market is determined by using valuation techniques. These valuation techniques maximize the use of observable market data where it is available and rely as little as possible on entity-specific estimates. If all significant inputs required to determine the fair value an instrument are observable, the instrument is included in level 2.

 

If one or more of the significant inputs is not based on observable market data, the instrument is included in level 3.

 

The following table presents Company assets and liabilities measured at fair value:

 

 

 

 

 

 

 

 

 

    

Level 1

    

Level 3

    

Total

 

 

U.S. dollars in thousands

December 31, 2017:

 

 

 

 

 

 

Assets -

 

 

 

 

 

 

Financial assets at fair value through profit or loss

 

16,587

 

 —

 

16,587

Liabilities -

 

 

 

 

 

 

Derivative financial instruments

 

 —

 

448

 

448

December 31, 2016:

 

 

 

 

 

 

Assets -

 

 

 

 

 

 

Financial assets at fair value through profit or loss

 

12,313

 

 —

 

12,313

Liabilities -

 

 

 

 

 

 

Derivative financial instruments

 

 —

 

6,155

 

6,155

 

The following table presents the change in derivative liabilities measured at level 3 for the years ended December 31, 2017 and 2016:

 

 

 

 

 

 

 

 

 

Derivative financial instruments

 

 

 

Year ended December 31

 

 

    

2017

    

2016

 

 

 

U.S. dollars in thousands

 

Balance at beginning of the year

 

6,155

 

1,237

 

Proceeds received during the reported year

 

 —

 

6,070

 

Exercise of derivative into shares

 

(20)

 

 —

 

Fair value adjustments recognized in profit or loss

 

(5,687)

 

(1,152)

 

Balance at the end of the year

 

448

 

6,155

 

 

The fair value of the above-mentioned derivative financial liabilities that are not traded in an active market is determined by using valuation techniques. The Company uses its judgment to select a variety of methods and make assumptions that are mainly based on market conditions existing at the end of each reporting period.

 

For more information regarding the derivatives, see note 15.

 

b.    Classification of financial instruments by groups:

 

 

 

 

 

 

 

 

 

    

Assets at
fair value
through
profit or loss

    

Loans and
receivables

    

Total

 

 

U.S. dollars in thousands

As of December 31, 2017:

 

 

 

  

 

 

Cash and cash equivalents

 

 —

 

16,455

 

16,455

Bank deposits

 

 —

 

13,315

 

13,315

Trade receivables

 

 —

 

1,528

 

1,528

Other receivables (except prepaid expenses)

 

 —

 

3,160

 

3,160

Financial assets at fair value through profit or loss

 

16,587

 

 —

 

16,587

 

 

16,587

 

34,458

 

51,045

As of December 31, 2016:

 

 

 

  

 

 

Cash and cash equivalents

 

 —

 

53,786

 

53,786

Bank deposits

 

 —

 

192

 

192

Trade receivables

 

 —

 

*99

 

99

Other receivables (except prepaid expenses)

 

 —

 

*1,442

 

1,442

Financial assets at fair value through profit or loss

 

12,313

 

 —

 

12,313

 

 

12,313

 

55,519

 

67,832

 

 

 

 

 

 

 

 

 

 

Financial

 

 

 

 

 

 

liabilities at

 

 

 

 

 

 

fair value

 

Financial

 

 

 

 

through

 

liabilities at

 

 

 

 

profit or

 

amortized

 

 

 

    

loss

    

cost

    

Total

 

 

U.S. dollars in thousands

As of December 31, 2017:

 

  

 

  

 

  

Accounts payable

 

 —

 

4,805

 

4,805

Accrued expenses and other current liabilities

 

 —

 

6,025

 

6,025

Derivative financial instruments

 

448

 

 —

 

448

Payable in respect of intangible asset purchase

 

 —

 

1,000

 

1,000

 

 

448

 

11,830

 

12,278

As of December 31, 2016:

 

 

 

 

 

 

Accounts payable

 

 —

 

*60

 

60

Accrued expenses and other current liabilities

 

 —

 

*3,296

 

3,296

Derivative financial instruments

 

6,155

 

 —

 

6,155

Payable in respect of intangible asset purchase

 

 —

 

2,000

 

2,000

 

 

6,155

 

5,356

 

11,511

 

 

 

 

 

 

 

 

*Reclassified to conform to the current year presentation. 

 

c.    Composition of financial instruments by currency:

 

 

 

 

 

 

 

 

 

 

 

 

Other

 

 

 

    

U.S. dollar

    

currencies

    

Total

 

 

U.S. dollars in thousands

As of December 31, 2017:

 

  

 

  

 

  

Assets:

 

  

 

  

 

  

Cash and cash equivalents

 

15,319

 

1,136

 

16,455

Bank deposits

 

13,101

 

214

 

13,315

Financial assets at fair value through profit or loss

 

16,587

 

 —

 

16,587

Trade receivable

 

1,528

 

 —

 

1,528

Other receivables (except prepaid expenses)

 

2,426

 

734

 

3,160

 

 

48,961

 

2,084

 

51,045

Liabilities:

 

  

 

  

 

  

Accounts payable

 

4,333

 

472

 

4,805

Accrued expenses and other currents liabilities

 

6,005

 

20

 

6,025

Payable in respect of intangible asset purchase

 

1,000

 

 —

 

1,000

Derivative financial instruments

 

448

 

 —

 

448

 

 

11,786

 

492

 

12,278

 

 

37,175

 

1,592

 

38,767

 

 

 

 

 

 

 

As of December 31, 2016:

 

 

 

 

 

 

Assets:

 

 

 

 

 

 

Cash and cash equivalents

 

51,936

 

1,850

 

53,786

Bank deposits

 

 —

 

192

 

192

Financial assets at fair value through profit or loss

 

12,313

 

 —

 

12,313

Receivables (except prepaid expenses)

 

1,078

 

463

 

1,541

 

 

65,327

 

2,505

 

67,832

Liabilities:

 

 

 

 

 

 

Accounts payable and accrued expenses

 

3,227

 

129

 

3,356

Payable in respect of intangible asset purchase

 

2,000

 

 —

 

2,000

Derivative financial instruments

 

6,155

 

 —

 

6,155

 

 

11,382

 

129

 

11,511

 

 

53,945

 

2,376

 

56,321